Peer Review History
| Original SubmissionSeptember 4, 2023 |
|---|
|
PONE-D-23-26559The contribution of abortive infection to preventing populations of Lactococcus lactis from succumbing to infections with bacteriophagePLOS ONE Dear Dr. Levin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 27 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Konstantinos Papadimitriou, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 2 in your text; if accepted, production will need this reference to link the reader to the Table. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments: Dear Authors, I believe that your study is interesting and of importance. However some major revisions are required before the study can be considered for publication. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors describe a model to predict how the phage resistome of Lactococcus lactis drives phage evolution in allowing them to overcome abortive infection systems among other challenges to proliferation. The manuscript is well written, clearly organised and well executed. The approach is thorough and is well articulated. Some minor comments below are suggested to improve the manuscript. 1. In the abstract, the authors should mention which genus of phages are being used and what Abi systems are present in the host that will be discussed in the manuscript. 2. The 936 group of phages have been reclassified as the Skunavirus genus. This should be updated in the manuscript. 3. The motivation for focusing on AbiZ is not clear. It's perfect to do so but needs explanation to the reader. 4. I cannot comment on the mathematical model but the approach seems rational and well considered. 5. The mutation rate is notably higher in p2 than P335. This difference is perhaps worth an explanation in the discussion. 6. Reviewer #2: line 16: maybe revised Background information is excessive, can be trimmed. Material & Methods - should describe the research methods and study design more clearly Results - the key findings of the study ought to be presented in a succinct fashion, generalities should be avoided. Line 17-23: too much background information for abstract. the sentence " to combat this.......... and CRISPR-Cas" could be removed. line 24: species name abbreviated Introduction: Line 39: I suggest rewording line 49-50: rephrase Line 51-52: what do you want to say here? kindly explain line 55-56: rephrase line 57-58: what do the authors want to say here? The concept of population dynamics of Abi explained. line 55-59 should be rephrased line 63-67: confusing and ambiguous line 69-73: Why are the study findings discussed at the end of introduction section, instead of outlining the objectives of the study?? Results: line 75: statistical analysis is missing. Avoid using general statements, merely describing an increase or decrease does not provide clarity, quantitative bent of your results would better convey the message line 82: can you provide the quantitative data for this. What is meant by proliferate exponentially? Did you calculate growth rate etc.? What do you mean by and how did you calculate the nutrient-limited densities? line 86-87: ambiguous statements, provide quantitative data. How did you evaluate this? Line 91-93: rephrase the sentences. What is meant by "as estimated"? line 94-98: Increases and decreases must be explained considering statistical differences. General result statements may not be helpful. Provide the quantitative data wherever is possible Line 100: rephrase. What do you want to say here? line 129-133: ambiguous... Abi- or (Abi-) are the abbreviations used or N and Nr Line 151-156: confusing. ? Can the equations be better explained here if that is the intent Line 159-160: any reference for this? Line 173: what do you mean by exactly by densities of bacteria and density of phages? line 183-184: Rephrase line 207-212: Not comprehensible. Line 215-216: how did you evaluate this? line 316: a critical and concise analysis of your results in the light of previously published literature is missing line 317: follow the same formatting throughout the manuscript line 321-322: The mathematical model does not appear to account the evolution of envelope resistance? Clarify line 351-354: rephrase the entire sentence Line 389: CFU/ml? Line 391-392: reason and ref? Line 395: bacterial name should be in italics throughout the manuscript Line 396: full name? line 402: ? define Abi escape. line 431-432: rephrase line 435: check? line 439: seems incomplete. short term experiment for?' Line 444: how? Line 513-514: how the densities were measured? Lin3 519: deg centigrade format is not correct Reviewer #3: The authors embark to elucidate the conditions under which abortive infection confers protection to Lactococcus lactis against phages. They developed and numerically analysed a mathematical model of the population dynamics and interactions of bacteria harbouring abortive infection and phages, followed by an experimental validation. Generally, the article is well written and clear. However, a few things require some attention. 1. The justification for the mathematical model's purpose, which is ‘to provide a framework for a comprehensive consideration of the population dynamics of phage and bacteria with abortive infection’, appears to lack sufficient support. The anticipation of resistance development, a foreseeable outcome based on existing knowledge, diminishes the model's scientific significance considerably. The authors should find a way to justify the importance of the mathematical model. 2. The mathematical model lacks some biologically relevant parameters like phage infection and replication rates in both ABI+ and ABI bacteria. Is there a reason why the authors did not include these parameters? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
The contribution of abortive infection to preventing populations of Lactococcus lactis from succumbing to infections with bacteriophage PONE-D-23-26559R1 Dear Dr. Levin, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Konstantinos Papadimitriou, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have fully addressed all of my previous queries and suggestions. It is a very nice manuscript that I believe will be of significant relevance to the field. Reviewer #3: Satisfied revision. All my concerns have been well addressed and I do not have more questions on this work. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-23-26559R1 PLOS ONE Dear Dr. Levin, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Konstantinos Papadimitriou Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .